Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohanraj Ramachandran

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Nature Communications|December 23, 2024
VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrierMiika Martikainen, Roberta Lugano, Ilkka Pietilä, et al.
Neuro-Oncology Advances|February 11, 2025
Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppressionGrzegorz Wicher, Ananya Roy, Alessandra Vaccaro, et al.
Nature Communications|August 10, 2023
Complementarity-determining region clustering may cause CAR-T cell dysfunctionTina Sarén, Giulia Saronio, Paula Marti Torrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2016
Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest VirusMohanraj Ramachandran, Di Yu, Matheus Dyczynski, et al.
Plos One|February 2, 2013
Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell culturesDi Yu, Chuan Jin, Mohanraj Ramachandran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2023
Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma PatientsTina Sarén, Mohanraj Ramachandran, Gustav Gammelgård, et al.
Neuro-Oncology|August 4, 2021
ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in gliomaHua Huang, Maria Georganaki, Lei Liu Conze, et al.
Oncoimmunology|April 2, 2020
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapyMaria Georganaki, Mohanraj Ramachandran, Sander Tuit, et al.
Cancer Cell|May 12, 2023
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in gliomaMohanraj Ramachandran, Alessandra Vaccaro, Tiarne van de Walle, et al.
Nature Communications|July 6, 2021
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in gliomaLuuk van Hooren, Alessandra Vaccaro, Mohanraj Ramachandran, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Nature Communications|December 23, 2024
VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrierMiika Martikainen, Roberta Lugano, Ilkka Pietilä, et al.
Neuro-Oncology Advances|February 11, 2025
Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppressionGrzegorz Wicher, Ananya Roy, Alessandra Vaccaro, et al.
Nature Communications|August 10, 2023
Complementarity-determining region clustering may cause CAR-T cell dysfunctionTina Sarén, Giulia Saronio, Paula Marti Torrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2016
Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest VirusMohanraj Ramachandran, Di Yu, Matheus Dyczynski, et al.
Plos One|February 2, 2013
Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell culturesDi Yu, Chuan Jin, Mohanraj Ramachandran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2023
Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma PatientsTina Sarén, Mohanraj Ramachandran, Gustav Gammelgård, et al.
Neuro-Oncology|August 4, 2021
ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in gliomaHua Huang, Maria Georganaki, Lei Liu Conze, et al.
Oncoimmunology|April 2, 2020
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapyMaria Georganaki, Mohanraj Ramachandran, Sander Tuit, et al.
Cancer Cell|May 12, 2023
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in gliomaMohanraj Ramachandran, Alessandra Vaccaro, Tiarne van de Walle, et al.
Nature Communications|July 6, 2021
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in gliomaLuuk van Hooren, Alessandra Vaccaro, Mohanraj Ramachandran, et al.
Pageof 3